CBIZ Investment Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.35K Hold
19
﹤0.01% 165
2026
Q1
$9.35K Sell
19
-99
-84% -$53.7K ﹤0.01% 165
2025
Q4
$68.4K Buy
118
+2
+2% +$1.13K ﹤0.01% 115
2025
Q3
$56.3K Buy
116
+27
+30% +$12.6K ﹤0.01% 117
2025
Q2
$36.1K Buy
89
+32
+56% +$13.4K ﹤0.01% 165
2025
Q1
$28.4K Buy
57
+33
+138% +$17.9K ﹤0.01% 176
2024
Q4
$12.5K Sell
24
-25
-51% -$13.7K ﹤0.01% 264
2024
Q3
$30.4K Hold
49
﹤0.01% 137
2024
Q2
$27.1K Sell
49
-6
-11% -$3.44K ﹤0.01% 132
2024
Q1
$32K Buy
+55
New +$30.9K ﹤0.01% 122
2020
Q1
Hold
0
154

Other funds holding TMO

CBIZ Investment Advisory Services's TMO Position: Q2 2026 in Review

CBIZ Investment Advisory Services held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 19 shares worth $9.35K. The position accounts for ﹤0.01% of the portfolio, ranked #165.

CBIZ Investment Advisory Services first reported a position in TMO in Q1 2024 and has held it in 10 quarters since. The position peaked at $68.4K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • CBIZ Investment Advisory Services held 19 shares of Thermo Fisher Scientific worth $9.35K as of Q2 2026.
  • CBIZ Investment Advisory Services left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of CBIZ Investment Advisory Services's portfolio in Q2 2026, its #165 holding.
  • CBIZ Investment Advisory Services first reported a position in Thermo Fisher Scientific in Q1 2024 and has held it in 10 quarters since.
  • CBIZ Investment Advisory Services's Thermo Fisher Scientific position peaked at $68.4K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on CBIZ Investment Advisory Services's 13F filing for Q2 2026, filed 13 Aug 2026.